Gradient Investments LLC Has $19.76 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX

NodeGuardian · 2026-03-23T19:53:04+00:00

Gradient Investments LLC raised its stake in Vertex Pharmaceuticals by 6.4%, holding 43,595 shares valued at $19.76 million. Despite a slight Q4 EPS miss, Vertex saw a 9.5% revenue increase, with analysts expecting strong earnings ahead.

NodeGuardian

2026-03-23 19:53:04

Abstract generation in progress

Gradient Investments LLC increased its stake in Vertex Pharmaceuticals (VRTX) by 6.4%, bringing its total holdings to 43,595 shares valued at $19.76 million. Other institutional investors also adjusted their holdings in the pharmaceutical company. Despite missing Q4 EPS estimates slightly, Vertex reported a 9.5% year-over-year revenue increase with analysts projecting strong earnings for the current year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.